Goldman sees the S&P 500 rallying to 4,300 by end of 2021 on vaccine, divided government

The Wall Street Bull (The Charging Bull) is seen during Covid-19 pandemic in Lower Manhattan, New York City, United States on May 26, 2020.
Tayfun Coskun | Anadolu Agency | Getty Images

(This story is for CNBC Pro subscribers only.)

Goldman Sachs has turned more bullish about the stock market on the back of the promising vaccine news and a divided U.S. government, now expecting a gain north of 20% for the S&P 500 by the end of next year.

The Wall Street firm on Wednesday hiked its year-end S&P 500 target to 3,700 from 3,600, a 4% rise from Tuesday's close of 3,545.53. By the end of 2021, Goldman expects the broad equity benchmark to rally to 4,300 — a 21% gain from the current level. The bank sees the S&P 500 reaching 4,600 by the end of 2022.

"A vaccine is a more important development for the economy and markets than the prospective policies of a Biden presidency," David Kostin, the bank's chief U.S. equity strategy, said in a note Wednesday. "The much-awaited results from Pfizer (PFE) that its COVID-19 vaccine has an efficacy rate greater than 90% is a positive event that will allow society to gradually normalize during 2021."

More In Street Calls

CNBC ProClean energy had a record year — here are Morgan Stanley's picks going forward
CNBC ProJPMorgan strategist Kolanovic, who nailed 2020 market, increases commodities bet as inflation hedge
CNBC ProHere are Friday's biggest analyst calls of the day: Apple, Spotify, Zoom, Snap, Tesla & more